Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

Daihan Pharmaceutical Revenue

Daihan Pharmaceutical had revenue of 49.89B KRW in the quarter ending March 31, 2025, with 1.78% growth. This brings the company's revenue in the last twelve months to 205.07B, up 3.13% year-over-year. In the year 2024, Daihan Pharmaceutical had annual revenue of 204.19B with 4.23% growth.

• Revenue (ttm): 205.07B
• Revenue Growth: +3.13%
• P/S Ratio: 0.86
• Revenue / Employee: 370.83M
• Employees: 553
• Market Cap: 176.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	204.19B	8.28B	4.23%
Dec 31, 2023	195.91B	11.64B	6.32%
Dec 31, 2022	184.27B	12.80B	7.47%
Dec 31, 2021	171.46B	5.38B	3.24%
Dec 31, 2020	166.08B	-2.68B	-1.59%